Cosmos Pharmaceutical Stock Cash And Equivalents
COSMOS Pharmaceutical fundamentals help investors to digest information that contributes to COSMOS Pharmaceutical's financial success or failures. It also enables traders to predict the movement of COSMOS Pink Sheet. The fundamental analysis module provides a way to measure COSMOS Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMOS Pharmaceutical pink sheet.
COSMOS |
COSMOS Pharmaceutical Company Cash And Equivalents Analysis
COSMOS Pharmaceutical's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, COSMOS Pharmaceutical has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
COSMOS Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COSMOS Pharmaceutical's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of COSMOS Pharmaceutical could also be used in its relative valuation, which is a method of valuing COSMOS Pharmaceutical by comparing valuation metrics of similar companies.COSMOS Pharmaceutical is currently under evaluation in cash and equivalents category among its peers.
COSMOS Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Shares Owned By Insiders | 51.47 % | |||
| Shares Owned By Institutions | 20.75 % | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| Gross Profit | 151.45 B | |||
| EBITDA | 48.21 B | |||
| Net Income | 23.16 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Number Of Employees | 5.1 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.89 B | |||
| Total Asset | 363.05 B | |||
| Z Score | 2.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 363.05 B | |||
| Last Dividend Paid | 40.0 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |